Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hemostemix Inc (TSE:HEM)
TSXV:HEM
Holding TSE:HEM?
Track your performance easily
HEM Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.04 - C$0.11
Previous CloseC$0.09
Volume135.00K
Average Volume (3M)187.54K
Market Cap
C$10.29M
Enterprise ValueC$14.80M
Total Cash (Recent Filing)C$103.75K
Total Debt (Recent Filing)C$4.62M
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Nov 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding87,122,318
10 Day Avg. Volume59,512
30 Day Avg. Volume187,541
Standard Deviation0.84
R-Squared0.00003
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)-0.85
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)25.40
P/FCF Ratio8.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hemostemix News
PremiumCompany Announcements
Hemostemix Secures $1.8M in Private Placement
PremiumCompany Announcements
Hemostemix Launches $4M Financing for Stem Cell Therapy Growth
PremiumCompany Announcements
Hemostemix Partners with CytoImmune, Boosts ACP-01 Production
PremiumCompany Announcements
Hemostemix Accelerates Cell Therapy Production with CytoImmuneOptions Prices
Currently, No data available
---
Ownership Overview
HEM FAQ
What was Hemostemix Inc’s price range in the past 12 months?
Hemostemix Inc lowest stock price was C$0.04 and its highest was C$0.11 in the past 12 months.
What is Hemostemix Inc’s market cap?
Currently, no data Available
When is Hemostemix Inc’s upcoming earnings report date?
Hemostemix Inc’s upcoming earnings report date is Nov 26, 2024 which is in 4 days.
How were Hemostemix Inc’s earnings last quarter?
Hemostemix Inc released its earnings results on Aug 29, 2024. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.
Is Hemostemix Inc overvalued?
According to Wall Street analysts Hemostemix Inc’s price is currently Overvalued.
Does Hemostemix Inc pay dividends?
Hemostemix Inc does not currently pay dividends.
What is Hemostemix Inc’s EPS estimate?
Hemostemix Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hemostemix Inc have?
Hemostemix Inc has 123,976,810 shares outstanding.
What happened to Hemostemix Inc’s price movement after its last earnings report?
Hemostemix Inc reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 20%.
Which hedge fund is a major shareholder of Hemostemix Inc?
Currently, no hedge funds are holding shares in TSE:HEM
---
Hemostemix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.42%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-20.10%
Trailing 12-Months
Company Description
Hemostemix Inc
Hemostemix Inc is a Canada based clinical-stage biotechnology company. Its principal business activity is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions. The company's technology platform for developing autologous cell therapies is for treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.
---
Technical Analysis
---